Kabuki-Za (TSE:9661) opened Q1 2027 with revenue of ¥905 million and basic EPS of ¥6.93, alongside net income of ¥84 million, setting a clear snapshot of the latest quarter. The company has seen quarterly revenue move between ¥853 million and ¥939 million over the last five reported periods, while basic EPS has ranged from ¥2.31 to ¥10.40, giving investors a sense of how earnings have tracked against a relatively tight revenue band. With trailing twelve month net margin slightly below the prior year, this set of results puts profitability quality and margin resilience at the center of the current Kabuki-Za earnings story.
See our full analysis for Kabuki-Za.With the headline figures in place, the next step is to set these results against the prevailing Kabuki-Za narratives to see which stories the numbers support and which they start to challenge.
Curious how numbers become stories that shape markets? Explore Community Narratives
With Kabuki-Za priced far above the provided DCF fair value and trading on a P/S multiple well beyond sector averages, it is worth seeing how other investors are interpreting this mix of strong history and richer valuation in the broader discussion Curious how numbers become stories that shape markets? Explore Community Narratives.
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Kabuki-Za's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
If the mixed tone on Kabuki-Za has you thinking, this is the moment to look directly at the figures and decide where you stand. To see the optimistic points analysts have identified, take a closer look at the 1 key reward.
Kabuki-Za shows a slower 5.2% trailing earnings growth rate, a slight net margin easing to 8.3%, and a P/S of 14.7x that is well above peers and the DCF fair value reference.
If that richer pricing and more measured growth leave you hesitant, you can compare Kabuki-Za with companies that look more attractively priced by running the 19 high quality undervalued stocks today.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com